« Previous
Next »
JAMDA
Volume 3, Issue 3
, Pages 175-179
, May 2002
Clinical Presentations in Monozygotic Twins with Dementia with Lewy Bodies
References
- Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology. 1996;47:1113–1124
- . Dementia with Lewy Bodies. New York: Cambridge, Melbourne: Cambridge University Press; 1996;
- Dementia with Lewy bodies: Findings from an international multicentre study. Int J Geriatr Psychiatry. 2000;15:1034–1045
- . An overview of common non-Alzheimer dementias. Clin Geriatr Med. 2001;7:281–301
- . Neuropathology of synuclein aggregates. J Neurosci Res. 2000;61:121–127
- Rivastigmine in the treatment of dementia with Lewy bodies: Preliminary findings from an open trial. Int J Geriatr Psychiatry. 2000;15:387–392
- . A comparison of sleep profiles in patients with dementia with Lewy bodies and Alzheimer's disease. Int J Geriatr Psychiatry. 2000;15:1028–1033
- . Improvement in sundowning in dementia with Lewy bodies after treatment with donepezil. Int J Geriatr Psychiatry. 2000;15:1147–1151
- Delusions associated with elevated muscarinic binding in dementia with Lewy bodies. Ann Neurol. 2000;48:868–876
- Efficacy of rivastigmine in dementia with Lewy bodies: A randomized, double blind, placebo-controlled international study. Lancet. 2000;356:2031–2036
- . Dementia with Lewy bodies: clinical features and treatment. Drugs Aging. 2001;18:397–407
- Hereditary form of parkinsonism–dementia. Ann Neurol. 1998;43:768–781
- Familial dementia with Lewy bodies (DLB). Clin Neuropath. 1999;18:232–239
- Distinctive neuropathology revealed by alpha-synuclein antibodies in hereditary parkinsonism and dementia linked to chromosom 4p,. Acta Neuropathol (Berl). 2000;99:663–672
- . Quantitative neuropathological study of Alzheimer-type pathology in the hippocampus: Comparison of senile dementia of Alzheimer type, senile dementia of Lewy body type, Parkinson's disease and non-demented elderly controls. J Neurol Sci. 1991;106:142–152
- Quantification and characterisation of fluctuating cognition in dementia with Lewy bodies and Alzheimer's disease. Dement Geriatr Cogn Disord. 2000;11:327–335
- The characterisation and impact of ‘fluctuating’ cognition in dementia with Lewy bodies and Alzheimer's disease. Int J Geriatr Psychiatry. 2001;16:494–498
- . The genetics of disorders with synuclein pathology and parkinsonism. Hum Mol Genet. 1999;8:1901–1905
- The CCTTT polymorphism in the NOS2A gene is associated with dementia with Lewy bodies. Neuroreport. 2000;11:297–299
- Striatal dopaminergic markers in dementia with Lewy bodies. Alzheimer's and Parkinson's diseases: rostrocaudal distribution, Brain. 1999;122:1449–1468
- Nicotine binding in human striatum: Elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication. Neuroscience. 2000;98:79–87
- McKeith IG, Perry EK, Perry RH. Report of the second dementia with Lewy body international workshop, Neurology 53;1999:902–905
PII: S1525-8610(04)70461-2
doi: 10.1016/S1525-8610(04)70461-2
© 2002 American Medical Directors Association. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
JAMDA
Volume 3, Issue 3
, Pages 175-179
, May 2002
